Revvity, Inc. (NYSE:RVTY) Shares Acquired by Deutsche Bank AG

Deutsche Bank AG boosted its holdings in Revvity, Inc. (NYSE:RVTY - Free Report) by 43.9% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 550,614 shares of the company's stock after acquiring an additional 167,918 shares during the quarter. Deutsche Bank AG owned about 0.45% of Revvity worth $61,454,000 as of its most recent filing with the SEC.

Several other large investors have also recently bought and sold shares of RVTY. T. Rowe Price Investment Management Inc. raised its position in Revvity by 16.7% in the fourth quarter. T. Rowe Price Investment Management Inc. now owns 20,761,308 shares of the company's stock worth $2,317,170,000 after acquiring an additional 2,969,326 shares in the last quarter. Price T Rowe Associates Inc. MD increased its position in shares of Revvity by 17.8% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 7,631,597 shares of the company's stock valued at $851,764,000 after buying an additional 1,151,821 shares in the last quarter. Norges Bank purchased a new position in shares of Revvity in the fourth quarter valued at $127,801,000. Invesco Ltd. increased its position in shares of Revvity by 18.8% in the fourth quarter. Invesco Ltd. now owns 1,740,933 shares of the company's stock valued at $194,306,000 after buying an additional 274,923 shares in the last quarter. Finally, Proficio Capital Partners LLC increased its position in shares of Revvity by 12,298.3% in the fourth quarter. Proficio Capital Partners LLC now owns 195,769 shares of the company's stock valued at $21,850,000 after buying an additional 194,190 shares in the last quarter. Hedge funds and other institutional investors own 86.65% of the company's stock.

Analyst Ratings Changes

A number of research analysts have recently weighed in on the company. JPMorgan Chase & Co. dropped their price target on Revvity from $120.00 to $100.00 and set a "neutral" rating for the company in a research report on Tuesday, April 29th. UBS Group upgraded Revvity from a "neutral" rating to a "buy" rating and dropped their price target for the company from $145.00 to $115.00 in a research report on Thursday, May 1st. KeyCorp raised their price target on Revvity from $132.00 to $145.00 and gave the company an "overweight" rating in a research report on Monday, February 3rd. Barclays dropped their price target on Revvity from $140.00 to $110.00 and set an "overweight" rating for the company in a research report on Thursday, April 10th. Finally, Wells Fargo & Company decreased their price objective on Revvity from $130.00 to $102.00 and set an "equal weight" rating on the stock in a research note on Thursday, April 17th. Four investment analysts have rated the stock with a hold rating, ten have issued a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $125.64.

Revvity Trading Up 3.1%

NYSE:RVTY traded up $2.81 during mid-day trading on Friday, reaching $93.21. The company's stock had a trading volume of 1,050,278 shares, compared to its average volume of 947,554. The company's fifty day simple moving average is $98.76 and its two-hundred day simple moving average is $110.25. The company has a debt-to-equity ratio of 0.41, a current ratio of 3.60 and a quick ratio of 3.03. Revvity, Inc. has a twelve month low of $88.53 and a twelve month high of $129.50. The stock has a market cap of $10.99 billion, a P/E ratio of 42.18, a P/E/G ratio of 3.82 and a beta of 1.02.

Revvity (NYSE:RVTY - Get Free Report) last issued its quarterly earnings results on Monday, April 28th. The company reported $1.01 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.96 by $0.05. Revvity had a return on equity of 7.68% and a net margin of 9.81%. The firm had revenue of $664.76 million for the quarter, compared to analyst estimates of $662.30 million. During the same period last year, the company earned $0.98 EPS. The firm's quarterly revenue was up 2.3% on a year-over-year basis. On average, equities analysts predict that Revvity, Inc. will post 4.94 EPS for the current year.

Revvity Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 8th. Stockholders of record on Friday, July 18th will be paid a $0.07 dividend. This represents a $0.28 annualized dividend and a dividend yield of 0.30%. The ex-dividend date is Friday, July 18th. Revvity's dividend payout ratio is currently 11.91%.

Revvity Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.